Evidence map›Paper›PMID 24509079›Full record

ArticleThe Journal of clinical investigation2014

B cells mediate chronic allograft rejection independently of antibody production.

Qiang Zeng, Yue-Harn Ng, Tripti Singh, Ke Jiang, Khaleefathullah A Sheriff, Renee Ippolito, Salwa Zahalka, Qi Li, Parmjeet Randhawa, Rosemary A Hoffman and 3 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 96 citations in OpenAlex.

  1. Suppression of cardiac allograft vasculopathy by a macrophage efferocytosis receptor.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  2. Article
  3. Review
  4. Science translational medicine · 2025
    Article
  5. Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Failing Heart Transplants and Rejection-A Cellular Perspective.Journal of cardiovascular development and disease · 2021
    Review
  17. IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Qiang Zeng
Yue-Harn Ng
Tripti Singh
Ke Jiang
Khaleefathullah A Sheriff
Renee Ippolito
Salwa Zahalka
Qi Li
Parmjeet Randhawa
Rosemary A Hoffman
Balathiripurasundari Ramaswami
Frances E Lund
Geetha Chalasani
University of Pittsburgh · USUniversity of Alabama at Birmingham · US

Funding

B Cells in the Pathogenesis of Allograft RejectionR01AI079177 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHALASANI, GEETHA · 2008 to 2021
$3.5M
Generation and maintenance of influenza-specific plasma and memory B cellsR01AI068056 · NIAID · UNIVERSITY OF ROCHESTER · PI LUND, FRANCES E. · 2006 to 2010
$2.3M
B cells in the pathogenesis of allograft rejectionR56AI079177 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHALASANI, GEETHA · 2014 to 2014
$385k
NIAID NIH HHS AI068056NIAID NIH HHS AI079177NIAID NIH HHS R01 AI068056NIAID NIH HHS R01 AI079177NIAID NIH HHS R56 AI079177
6 · The paper itself

Abstract

Chronic rejection is the primary cause of long-term failure of transplanted organs and is often viewed as an antibody-dependent process. Chronic rejection, however, is also observed in mice and humans with no detectable circulating alloantibodies, suggesting that antibody-independent pathways may also contribute to pathogenesis of transplant rejection. Here, we have provided direct evidence that chronic rejection of vascularized heart allografts occurs in the complete absence of antibodies, but requires the presence of B cells. Mice that were deficient for antibodies but not B cells experienced the same chronic allograft vasculopathy (CAV), which is a pathognomonic feature of chronic rejection, as WT mice; however, mice that were deficient for both B cells and antibodies were protected from CAV. B cells contributed to CAV by supporting splenic lymphoid architecture, T cell cytokine production, and infiltration of T cells into graft vessels. In chimeric mice, in which B cells were present but could not present antigen, both T cell responses and CAV were markedly reduced. These findings establish that chronic rejection can occur in the complete absence of antibodies and that B cells contribute to this process by supporting T cell responses through antigen presentation and maintenance of lymphoid architecture.

Indexed as

Antibody FormationAllograftsAnimalsAntigen PresentationB-LymphocytesCells, CulturedCoculture TechniquesCytokinesGraft RejectionHeart TransplantationMiceMice, Inbred BALB CMice, KnockoutMyocardiumT-LymphocytesCytokines

Identifiers

PMID24509079
PMCPMC3934170
OpenAlexW1975484438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.